Related Experiment Video

Updated: Aug 9, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

Alternative splicing and gene structure of the transforming growth factor beta-activated kinase 1

C E Dempsey1, H Sakurai, T Sugita

  • 1Functional Genomics Group, Division of Molecular and Genetic Medicine, University of Sheffield, Royal Hallamshire Hospital, Sheffield, UK.

Biochimica Et Biophysica Acta
|December 19, 2000
PubMed

Insights

Researchers discovered a new splice variant, TAK1-d, and corrected the TAK1-c sequence. These TGF beta-activated kinase (TAK1) variants exhibit distinct protein structures and variable tissue expression, suggesting functional implications of alternative splicing.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Signaling

Background:

  • Transforming growth factor beta-activated kinase 1 (TAK1) is a key regulator in cellular signaling pathways.
  • Previous studies identified three splice variants (TAK1-a, TAK1-b, TAK1-c) of TAK1.
  • Understanding TAK1 splice variants is crucial for elucidating its diverse biological roles.

Purpose of the Study:

  • To identify and characterize novel splice variants of TAK1.
  • To investigate the structural differences between TAK1 splice variants.
  • To analyze the tissue-specific expression patterns of TAK1 splice variants.

Main Methods:

  • Bioinformatic analysis of the human TAK1 gene sequence.
  • Identification and sequencing of splice variants.
  • Quantitative analysis of mRNA expression levels across different human tissues.

Main Results:

  • A fourth splice variant, TAK1-d, was identified, and an error in the TAK1-c sequence was corrected.
  • TAK1-c and TAK1-d variants encode proteins with distinct carboxyl termini compared to TAK1-a and TAK1-b.
  • Alternative splicing of exons 12 and 16 in the human TAK1 gene (6q16.1-q16.3) generates the four identified splice variants.
  • Significant variations in the relative expression levels of the four TAK1 splice variants were observed across different tissues.

Conclusions:

  • The alternative splicing of TAK1 mRNA leads to structurally distinct protein isoforms.
  • Tissue-specific expression patterns suggest functional specialization of TAK1 splice variants.
  • Alternative splicing of TAK1 mRNA likely plays a significant role in regulating cellular responses and biological functions.

More Related Videos

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...